BRAF mutation in metastatic colorectal cancer

N Engl J Med. 2009 Jul 2;361(1):98-9. doi: 10.1056/NEJMc0904160.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Cetuximab
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Disease Progression
  • Genes, ras*
  • Genetic Markers
  • Humans
  • Mutation*
  • Neoplasm Metastasis / genetics
  • Prognosis
  • Proto-Oncogene Proteins B-raf / genetics*
  • Retrospective Studies
  • Survival Analysis

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Genetic Markers
  • Bevacizumab
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Cetuximab